The resource hub to learn more about LIT™ and the latest publications and news from Seroxo
Publications
Real-time Measurement of Oxidative Stress During Ex Vivo Liver Perfusion as a Biomarker of Graft Injury and Viability
Poster presented at UNOS Transplant Medicine Conference, Atlanta, April 2026
Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases
Intensive Care Medicine Experimental
High generation of reactive oxygen species from neutrophils in patients with severe COVID‑19
Nature Scientific Reports
GRANT-FUNDED PROJECTS IN SEROXO
-
EU
1 Sep 21 - 30 Sep 2022
INNO4COV - Point of care test of leukocyte function using LIT to assess and guide COVID patient management
-
Innovate UK
1 Oct 20 - 30 Nov 2021
Development of home blood monitoring test for cancer patients to reduce need for hospital visits
-
Innovate UK
1 Jan 22 - 31 Mar 2022
Leukocyte ImmunoTest(TM): Feasibility study to develop links with sepsis clinical experts and organisations in the USA
-
Innovate UK
1 Nov 22 - 30 Apr 2023
Design Foundation: Innovative design of near-patient test for early detection and monitoring of maternal and neonatal sepsis
-
NIHR
1 May 23 -30 Apr 24
NIHR-I4I-Connect: Investigative pilot study of the diagnostic potential of a rapid point-of-care blood test in distinguishing between non-metastatic and metastatic breast cancer
Latest News
•BBC NEWS "Sepsis failings still causing too many deaths"
•BBC NEWS "Sepsis failings still causing too many deaths"
Jun 2026-Seroxo Announces Landmark Peer-Reviewed Clinical Study Supporting the Leukocyte ImmunoTest™ (LIT™) Platform for Rapid Assessment of Infection and Sepsis
Apr 2026-Cleveland Clinic Research Highlights Potential of Seroxo's Leukocyte ImmunoTest™ (LIT™) for Real-Time Assessment of Donor Liver Viability During Machine Perfusion
July 2023-Seroxo commences i4i-Connect breast cancer clinical project funded by NIHR
Oct 2023-BBC News "Sepsis failings still causing too many deaths"